JMP Securities Downgrades Optimer Pharmaceuticals (OPTR) to Market Perform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. GOOGL
6. RTX
7. COF
8. SMCI
9. TSLA
10. BRZE

Go back to JMP Securities Downgrades Optimer Pharmaceuticals (OPTR) to Market Perform

Optimer Pharmaceuticals (OPTR) Posts Q2 Profit of $0.02/Sh

February 28, 2013 4:29 PM EST

Optimer Pharmaceuticals (NASDAQ: OPTR) reported Q4 EPS of $0.02, which may not compare to the estimate of ($0.38). Revenue for the quarter came in at $19.5 million versus the consensus estimate of $18.05 million.

"2012 was an exciting year for Optimer. DIFICID is now available in over a... More